Bragg Financial Advisors’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,395
| Closed | -$233K | – | 321 |
|
|
2024
Q1 | $233K | Sell |
8,395
-5,842
| -41% | -$130K | 0.01% | 311 |
|
|
2023
Q4 | $274K | Sell |
14,237
-213,847
| -94% | -$3.87M | 0.01% | 289 |
|
|
2023
Q3 | $3.69M | Buy |
228,084
+20,438
| +10% | +$363K | 0.19% | 130 |
|
|
2023
Q2 | $3.95M | Buy |
207,646
+962
| +0.5% | +$17.2K | 0.22% | 126 |
|
|
2023
Q1 | $3.01M | Sell |
206,684
-435
| -0.2% | -$7.79K | 0.18% | 138 |
|
|
2022
Q4 | $4.05M | Sell |
207,119
-50,449
| -20% | -$984K | 0.25% | 124 |
|
|
2022
Q3 | $6.21M | Buy |
257,568
+49,621
| +24% | +$1.53M | 0.43% | 96 |
|
|
2022
Q2 | $6.54M | Buy |
207,947
+334
| +0.2% | +$12.1K | 0.43% | 93 |
|
|
2022
Q1 | $9.14M | Buy |
207,613
+1,155
| +0.6% | +$49.6K | 0.53% | 77 |
|
|
2021
Q4 | $6.46M | Hold |
206,458
| – | – | 0.41% | 95 |
|
|
2021
Q3 | $6.46M | Buy |
206,458
+473
| +0.2% | +$18.6K | 0.41% | 95 |
|
|
2021
Q2 | $8.72M | Hold |
205,985
| – | – | 0.56% | 74 |
|
|
2021
Q1 | $7.74M | Buy |
205,985
+87,727
| +74% | +$2.74M | 0.52% | 78 |
|
|
2020
Q4 | $3.2M | Buy |
118,258
+2,940
| +3% | +$75.6K | 0.28% | 110 |
|
|
2020
Q3 | $2.9M | Buy |
115,318
+20,779
| +22% | +$303K | 0.3% | 100 |
|
|
2020
Q2 | $720K | Buy |
94,539
+2,940
| +3% | +$21.5K | 0.08% | 167 |
|
|
2020
Q1 | $838K | Buy |
91,599
+27,993
| +44% | +$169K | 0.11% | 156 |
|
|
2019
Q4 | $329K | Hold |
63,606
| – | – | 0.04% | 225 |
|
|
2019
Q3 | $370K | Hold |
63,606
| – | – | 0.05% | 213 |
|
|
2019
Q2 | $204K | Buy |
63,606
+96
| +0.2% | +$327 | 0.03% | 264 |
|
|
2019
Q1 | $260K | Buy |
63,510
+660
| +1% | +$4.17K | 0.03% | 239 |
|
|
2018
Q4 | $398K | Buy |
+62,850
| New | +$652K | 0.06% | 197 |
|
|
2018
Q3 | – | Sell |
-12,159
| Closed | -$203K | – | 254 |
|
|
2018
Q2 | $203K | Sell |
12,159
-3,637
| -23% | -$58.9K | 0.03% | 252 |
|
|
2018
Q1 | $246K | Sell |
15,796
-65,063
| -80% | -$1.16M | 0.04% | 238 |
|
|
2017
Q4 | $1.53M | Sell |
80,859
-2,490
| -3% | -$55.2K | 0.22% | 135 |
|
|
2017
Q3 | $2.43M | Sell |
83,349
-34,191
| -29% | -$1.01M | 0.37% | 103 |
|
|
2017
Q2 | $3.78M | Hold |
117,540
| – | – | 0.6% | 63 |
|
|
2017
Q1 | $4.07M | Buy |
117,540
+930
| +0.8% | +$33.2K | 0.65% | 59 |
|
|
2016
Q4 | $4.12M | Buy |
116,610
+31,155
| +36% | +$1.05M | 0.68% | 59 |
|
|
2016
Q3 | $2.97M | Hold |
85,455
| – | – | 0.53% | 76 |
|
|
2016
Q2 | $3.19M | Buy |
85,455
+9,678
| +13% | +$364K | 0.58% | 67 |
|
|
2016
Q1 | $3.06M | Buy |
75,777
+8,300
| +12% | +$309K | 0.59% | 63 |
|
|
2015
Q4 | $2.43M | Buy |
67,477
+10,896
| +19% | +$394K | 0.52% | 76 |
|
|
2015
Q3 | $1.81M | Sell |
56,581
-535
| -0.9% | -$18.2K | 0.43% | 89 |
|
|
2015
Q2 | $1.94M | Hold |
57,116
| – | – | 0.44% | 89 |
|
|
2015
Q1 | $1.93M | Buy |
57,116
+1,532
| +3% | +$53.4K | 0.45% | 90 |
|
|
2014
Q4 | $1.95M | Sell |
55,584
-717
| -1% | -$24.1K | 0.47% | 87 |
|
|
2014
Q3 | $1.84M | Sell |
56,301
-1,030
| -2% | -$35.1K | 0.47% | 84 |
|
|
2014
Q2 | $1.95M | Hold |
57,331
| – | – | 0.47% | 82 |
|
|
2014
Q1 | $2.01M | Sell |
57,331
-410
| -0.7% | -$14.5K | 0.49% | 82 |
|
|
2013
Q4 | $2.11M | Hold |
57,741
| – | – | 0.51% | 78 |
|
|
2013
Q3 | $2M | Buy |
57,741
+740
| +1% | +$25.9K | 0.52% | 76 |
|
|
2013
Q2 | $1.93M | Buy |
+57,001
| New | +$1.89M | 0.53% | 75 |
|
Other funds holding ACH
DM
Bragg Financial Advisors's ACH Position: Q2 2024 in Review
Bragg Financial Advisors sold out of Accendra Health (ACH) in Q2 2024, closing a stake of 8,395 shares — an estimated $233K sold.
Bragg Financial Advisors first reported a position in ACH in Q2 2013 and held it in 43 quarters. The position peaked at $9.14M in Q1 2022. 221 funds tracked by Wall St. Rank hold ACH as of Q2 2024.
- Bragg Financial Advisors reported no remaining Accendra Health position as of Q2 2024 after selling out during the quarter.
- Bragg Financial Advisors sold 8,395 Accendra Health shares in Q2 2024, an estimated $233K.
- Bragg Financial Advisors first reported a position in Accendra Health in Q2 2013 and held it in 43 quarters.
- Bragg Financial Advisors's Accendra Health position peaked at $9.14M in Q1 2022.
- 221 funds tracked by Wall St. Rank held Accendra Health as of Q2 2024.
Based on Bragg Financial Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.